News | Artificial Intelligence | February 01, 2024

A new paper in JAMA describes how, despite widespread enthusiasm about AI’s potential and the current use of AI-powered tools, no federal regulations require that AI-powered tools be evaluated for potential harm or benefit to patients 

A new paper in JAMA describes how, despite widespread enthusiasm about AI’s potential and the current use of AI-powered tools, no federal regulations require that AI-powered tools be evaluated for potential harm or benefit to patients

John W. Ayers, Ph.D., is deputy director of informatics in Altman Clinical and Translational Research Institute and a Qualcomm Institute affiliate at University of California, San Diego. Image courtesy of Qualcomm Institute at UC San Diego 


February 1, 2024 — Ever wonder if the latest and greatest artificial intelligence (AI) tool you read about in the morning paper is going to save your life? A new study published in JAMA led by John W. Ayers, Ph.D., of the Qualcomm Institute within the University of California San Diego, finds that question can be difficult to answer since AI products in healthcare do not universally undergo any externally evaluated approval process assessing how it might benefit patient outcomes before coming to market. 

The research team evaluated the recent White House Executive Order that instructed the Department of Health and Human Services to develop new AI-specific regulatory strategies addressing equity, safety, privacy, and quality for AI in healthcare before April 27, 2024. However, team members were surprised to find the order did not once mention patient outcomes, the standard metric by which healthcare products are judged before being allowed to access the healthcare marketplace.  

“The goal of medicine is to save lives,” said Davey Smith, M.D., head of the Division of Infectious Disease and Global Public Health at UC San Diego School of Medicine, co-director of the university’s Altman Clinical and Translational Research Institute, and study senior author. “AI tools should prove clinically significant improvements in patient outcomes before they are widely adopted.” 

According to the team, AI-powered early warning systems for sepsis, a fatal acute illness among hospitalized patients that affects 1.7 million Americans each year, demonstrates the consequences of inadequate prioritization of patient outcomes in regulations. A third-party evaluation of the most widely adopted AI sepsis prediction model revealed 67% of patients who developed sepsis were not identified by the system. Would hospital administrators have chosen this sepsis prediction system if trials assessing patient outcomes data were mandated, the team wondered, considering the array of available early warning systems for sepsis? 

“We are calling for a revision to the White House Executive Order that prioritizes patient outcomes when regulating AI products,” added John W. Ayers, Ph.D., who is deputy director of informatics in Altman Clinical and Translational Research Institute in addition to his Qualcomm Institute affiliation. “Similar to pharmaceutical products, AI tools that impact patient care should be evaluated by federal agencies for how they improve patients' feeling, function, and survival.” 

The team points to its 2023 study in JAMA Internal Medicine on using AI-powered chatbots to respond to patient messages as an example of what patient outcome-centric regulations can achieve. “Theoretically, a study comparing standard care versus standard care enhanced by AI conversational agents might find differences in downstream care utilization in some patient populations, such as heart failure patients,” said Nimit Desai, B.S., who is a research affiliate at the Qualcomm Institute, UC San Diego School of Medicine student, and study coauthor. “But studies like this don’t just happen unless regulators appropriately incentivize them. With a patient outcomes-centric approach, AI for patient messaging and all other clinical applications can truly enhance people’s lives.” 

The team recognizes that its proposed regulatory strategy can be a significant lift for AI and healthcare industry partners and may not be necessary for every flavor of AI use case in healthcare. However, the researchers say, excluding patient outcomes-centric rules in the White House Executive Order is a serious omission.  

The piece, “Regulate Artificial Intelligence in Health Care by Prioritizing Patient Outcomes,” (doi:10.1001/jama.2024.0549) was published by JAMA on January 29, 2024. 

For more information: https://ucsd.edu/ 


Related Content

News | Enterprise Imaging

June 20, 2024 — Agfa announces its participation in the upcoming Society for Imaging Informatics in Medicine (SIIM) 2024 ...

Time June 20, 2024
arrow
News | SIIM

June 20, 2024 — The Society for Imaging Informatics in Medicine (SIIM) is gearing up for its SIIM24 Annual Meeting and ...

Time June 20, 2024
arrow
News | Cybersecurity

June 19, 2024 —Karamba Security, a world leader in end-to-end product security, today announced the signing of a ...

Time June 19, 2024
arrow
News | Artificial Intelligence

June 18, 2024 — The advancement of Artificial Intelligence (AI) in healthcare to support diagnostic decision making ...

Time June 18, 2024
arrow
News | PACS

June 13, 2024 — Cloud-PACS radiology solutions provider SynthesisHealth, Inc. has signed three new contracts with ...

Time June 13, 2024
arrow
News | Digital Radiography (DR)

June 12, 2024 — Carestream launched its Image Suite MR 10 Software to help deliver a boost to productivity and ...

Time June 12, 2024
arrow
News | Enterprise Imaging

June 12, 2024 — Mach7 Technologies, a company specializing in innovative medical imaging and data management solutions ...

Time June 12, 2024
arrow
News | Artificial Intelligence

June 6, 2024 — Sunway Medical Centre, Sunway City (SMC), the largest private quaternary hospital in Malaysia, embarks on ...

Time June 06, 2024
arrow
News | Digital Radiography (DR)

June 6, 2024 — In a landmark study, the latest in technology innovation by Konica Minolta Healthcare was used to develop ...

Time June 06, 2024
arrow
News | Artificial Intelligence

June 5, 2024 — Nano-X Imaging, an innovative medical imaging technology company, today announced that its deep-learning ...

Time June 05, 2024
arrow
Subscribe Now